Elevated glutamine triggers stroke risk in moyamoya disease via endothelial‐to‐mesenchymal transition, finds study
A study led by Dr. Jizong Zhao, Dr. Dong Zhang, and Dr. Peicong Ge explores the role of glutamine in stroke risk for Moyamoya disease (MMD) patients. Elevated serum glutamine levels were linked to increased stroke risk in MMD. The study found that manipulating integrin subunit beta 4 (ITGB4) and using atorvastatin could alleviate the…